文献速递糖尿病

胰腺移植:当前挑战、考量与争议

Pancreas Transplantation: Current Challenges, Considerations, and Controversies.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

胰腺移植可重建内源性胰岛素的自调节来源,使患者摆脱外源性胰岛素并改善生活质量与预期寿命,但需大型手术和长期免疫抑制。尽管疗效持续改善且受体选择扩展至2型糖尿病表型,新千年胰腺移植数量下降,与转诊缺乏、共识标准缺失及移植界可及性等问题相关。作者认为胰腺移植应在胰岛素治疗失败的糖尿病患者管理中占据更突出位置,所有糖尿病合并慢性肾脏病患者均应考虑胰肾联合移植。

要点

  • 成功的胰腺移植可恢复内源性胰岛素分泌,改善血糖波动和生活质量。
  • 胰腺移植被视为治疗而非治愈,需大型手术和长期免疫抑制。
  • 新千年胰腺移植数量下降,与转诊缺乏、共识标准缺失及可及性问题相关。

核心结论

  • 胰腺移植应更突出地纳入胰岛素需要型糖尿病且外源性胰岛素治疗失败或出现进行性糖尿病并发症患者的管理路径,无论糖尿病类型。
  • 所有糖尿病合并慢性肾脏病患者均应考虑胰肾联合移植,不受地理或位置限制。

研究设计与样本

  • 综述,总结胰腺移植的当前挑战、考量与争议。

主要发现

  • 成功的胰腺移植提供内源性胰岛素、反调节激素分泌和外分泌功能,减轻血糖波动,消除糖尿病日常负担,改善生活质量和预期寿命。
  • 胰腺移植需大型手术和长期免疫抑制,被视为治疗而非治愈。
  • 尽管疗效持续改善且受体选择标准扩展至2型糖尿病表型,新千年胰腺移植数量下降。
  • 作者经验中,潜在候选患者感觉需要绕过常规糖尿病诊疗模式才能获得移植选择。

临床怎么用

  • 作者认为胰腺移植应更突出地纳入胰岛素需要型糖尿病且外源性胰岛素治疗失败或出现进行性糖尿病并发症患者的管理路径,无论糖尿病类型。
  • 作者认为所有糖尿病合并慢性肾脏病患者均应考虑胰肾联合移植,不受地理或位置限制。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pancreas transplantation (PTx) reestablishes an autoregulating source of endogenous insulin responsive to normal feedback controls. In addition to achieving complete β-cell replacement that frees the patient with diabetes from the need to monitor serum glucose and administer exogenous insulin, successful PTx provides counterregulatory hormone secretion and exocrine function. A functioning PTx mitigates glycemic variability, eliminates the daily stigma and burden of diabetes, restores normal glucose homeostasis in patients with complicated diabetes, and improves quality of life and life expectancy. The tradeoff is that it entails a major surgical procedure and requisite long-term immunosuppression. Despite the high likelihood of rendering patients euglycemic independent of exogenous insulin, PTx is considered a treatment rather than a cure. In spite of steadily improving outcomes in each successive era coupled with expansion of recipient selection criteria to include patients with a type 2 diabetes phenotype, a decline in PTx activity has occurred in the new millennium related to a number of factors including: (1) lack of a primary referral source and general acceptance by the diabetes care community; (2) absence of consensus criteria; and (3) access, education, and resource issues within the transplant community. In the author's experience, patients who present as potential candidates for PTx have felt as though they needed to circumvent the conventional diabetes care model to gain access to transplant options. PTx should be featured more prominently in the management algorithms for patients with insulin requiring diabetes who are failing exogenous insulin therapy or experiencing progressive diabetic complications regardless of diabetes type. Furthermore, all patients with diabetes and chronic kidney disease should undergo consideration for simultaneous pancreas-kidney transplantation independent of geography or location.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Fridell JA, Stratta RJ, Gruessner AC, et al. Pancreas Transplantation: Current Challenges, Considerations, and Controversies. J Clin Endocrinol Metab. 2023. PMID: 36377963. doi:10.1210/clinem/dgac644

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。